1. Academic Validation
  2. Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9

Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9

  • Blood. 2015 Dec 17;126(25):2734-8. doi: 10.1182/blood-2015-09-659854.
Klaus Schmitz-Abe 1 Szymon J Ciesielski 2 Paul J Schmidt 3 Dean R Campagna 4 Fedik Rahimov 1 Brenda A Schilke 2 Marloes Cuijpers 5 Klaus Rieneck 6 Birgitte Lausen 7 Michael L Linenberger 8 Anoop K Sendamarai 3 Chaoshe Guo 3 Inga Hofmann 9 Peter E Newburger 10 Dana Matthews 11 Akiko Shimamura 11 Pieter J L M Snijders 12 Meghan C Towne 13 Charlotte M Niemeyer 14 Henry G Watson 15 Morten H Dziegiel 6 Matthew M Heeney 9 Alison May 16 Sylvia S Bottomley 17 Dorine W Swinkels 18 Kyriacos Markianos 1 Elizabeth A Craig 2 Mark D Fleming 3
Affiliations

Affiliations

  • 1 Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA; Harvard Medical School, Boston, MA;
  • 2 Department of Biochemistry, University of Wisconsin, Madison, WI;
  • 3 Harvard Medical School, Boston, MA; Department of Pathology, Boston Children's Hospital, Boston, MA;
  • 4 Department of Pathology, Boston Children's Hospital, Boston, MA;
  • 5 Department of Internal Medicine, Viecuri Medical Centre, Venlo, The Netherlands;
  • 6 Department of Clinical Immunology, and.
  • 7 Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark;
  • 8 Division of Hematology, University of Washington, Seattle, WA;
  • 9 Harvard Medical School, Boston, MA; Department of Pediatrics, Dana-Farber Cancer Institute-Boston Children's Center for Cancer and Blood Disorders, Boston, MA;
  • 10 Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA;
  • 11 Division of Hematology, Seattle Children's Hospital, Seattle, WA;
  • 12 Huisartsenteam Sint Willebrord, Sint Willebrord, The Netherlands;
  • 13 Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA;
  • 14 Pediatric Hematology and Oncology Department, Children's Hospital, University of Freiburg, Freiburg, Germany;
  • 15 Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, Scotland;
  • 16 Department of Haematology, Cardiff University School of Medicine, Heath Park, Cardiff, Wales;
  • 17 Department of Medicine, Hematology-Oncology Section, University of Oklahoma College of Medicine, Oklahoma City, OK; and.
  • 18 Department of Laboratory Medicine, Translational Metabolic Laboratory, Radboud University Medical Centre, Nijmegen, The Netherlands.
Abstract

The congenital sideroblastic anemias (CSAs) are relatively uncommon diseases characterized by defects in mitochondrial heme synthesis, iron-sulfur (Fe-S) cluster biogenesis, or protein synthesis. Here we demonstrate that mutations in HSPA9, a mitochondrial HSP70 homolog located in the chromosome 5q deletion syndrome 5q33 critical deletion interval and involved in mitochondrial Fe-S biogenesis, result in CSA inherited as an autosomal recessive trait. In a fraction of patients with just 1 severe loss-of-function allele, expression of the clinical phenotype is associated with a common coding single nucleotide polymorphism in trans that correlates with reduced messenger RNA expression and results in a pseudodominant pattern of inheritance.

Figures